UK markets closed

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.31-0.36 (-1.93%)
At close: 04:00PM EDT
18.31 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-137,245
-145,224
-325,991
-290,581
71,136
Depreciation & amortisation
8,841
16,726
10,383
8,593
8,531
Stock-based compensation
107,858
108,102
99,847
85,247
50,351
Change in working capital
-327,314
-289,926
-24,030
-20,412
288,401
Accounts payable
-632
2,431
2,274
3,705
-1,623
Other working capital
-425,112
-370,930
-262,549
-219,889
413,057
Other non-cash items
-3,797
-3,717
-3,288
-2,984
-2,322
Net cash provided by operating activities
-412,809
-357,991
-244,716
-211,389
416,152
Cash flows from investing activities
Investments in property, plant and equipment
-12,303
-12,939
-17,833
-8,500
-3,095
Purchases of investments
-2,124,143
-1,813,700
-1,115,040
-1,422,938
-1,285,468
Sales/maturities of investments
2,025,282
2,075,947
991,486
1,409,812
665,357
Net cash used for investing activities
-111,164
249,308
-141,387
-21,626
-623,206
Cash flows from financing activities
Common stock issued
499,253
0
296,215
0
614,094
Net cash used provided by (used for) financing activities
516,491
17,820
310,670
19,348
634,749
Net change in cash
-7,482
-90,863
-75,433
-213,667
427,695
Cash at beginning of period
69,631
219,544
294,977
508,644
80,949
Cash at end of period
62,149
128,681
219,544
294,977
508,644
Free cash flow
Operating cash flow
-412,809
-357,991
-244,716
-211,389
416,152
Capital expenditure
-12,303
-12,939
-17,833
-8,500
-3,095
Free cash flow
-425,112
-370,930
-262,549
-219,889
413,057